Speaker: 

Christine Roussel, PharmD, RPh, BCOP, BSCSP - System Director of Pharmacy Quality Safety and Compliance​, Geisinger Health System​ - has nothing to disclose.

Moderator: 

Tristan Maiers, PharmD, BCOP, Central Region Hematology/Oncology Pharmacy Manager - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the current legal and regulatory landscape surrounding cannabis, including Pennsylvania’s Medical Marijuana Program, evolving federal policies, and the emergence of hemp-derived THC products.
• Discuss the safety considerations and clinical implications of cannabis use, including potential medication interactions and effects on cognition, coordination, and cardiovascular health.
• Identify key factors that contribute to responsible cannabis use, including differences in THC and CBD content, product formulations, dosing considerations, and the importance of product sourcing and labeling.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Rajiv Panikkar, MD, Michele Long, BSN, Jaime Weeder, NP, Erika Bross, PA, and Jeanne Braunstein, CphT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.